Clinical Trial Update: Randomized, Placebo-controlled Trial of an AMPAkine in Major Depressive Disorder [Phase 2]

View source ↗

Summary

A Phase 2 randomized, placebo-controlled trial of an AMPAkine for major depressive disorder was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• AMPAkine (unspecified)

Snippet

Sponsor: Dennis Charney | Conditions: Major Depressive Disorder | Phase 2 | Status: WITHDRAWN